The purpose of the study is to assess the safety and tolerability of AZD2066 and to explore the effect of a single dose of AZD2066 on the function of the cardia (the opening between the stomach and the esophagus) compared to placebo (not containing any medical substance) in healthy volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
40
Research site
Amsterdam, Netherlands
Manometry
Time frame: 3.45 hours each study period
pH
Time frame: 3.45 hours each study period
Impedance
Time frame: 3.45 hours each study period
Pharmacokinetic variables
Time frame: 3.45 hours each study period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dose to be decided after Part A, including dose A (active) and B (placebo). Oral solution, 1 single dose
Oral solution, 1 single dose